How I Treat <i>TP53</i>-Mutated Acute Myeloid Leukemia and Myelodysplastic Syndromes

How I Treat <i>TP53</i>-Mutated Acute Myeloid Leukemia and Myelodysplastic Syndromes

<i>TP53</i>-mutated acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) are among the myeloid malignancies with the poorest prognosis. In this review, we analyze the prognosis of these two diseases, focussing particularly on the extent of the mono or biallelic mutation statu...

Full description

Bibliographic Details
Main Authors:	Michael Loschi, Pierre Fenaux, Thomas Cluzeau
Format:	Article
Language:	English
Published:	MDPI AG 2022-09-01
Series:	Cancers
Subjects:	AML <i>TP53</i> magrolimab eprenetapopt allogeneic stem cell transplantation
Online Access:	https://www.mdpi.com/2072-6694/14/18/4519

Similar Items

Personalized Medicine for TP53 Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia
by: Thomas Cluzeau, et al.
Published: (2021-09-01)

Are We Moving the Needle for Patients with <i>TP53</i>-Mutated Acute Myeloid Leukemia?
by: Rory M. Shallis, et al.
Published: (2022-05-01)

TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with <i>TP53</i> Mutation/Deletion
by: Eric D. Eisenmann, et al.
Published: (2022-12-01)

Targeting CD47/SIRPα in Acute Myeloid Leukemia and Myelodysplastic Syndrome: Preclinical and Clinical Developments of Magrolimab
by: Fadi Haddad, et al.
Published: (2021-05-01)

The Current Understanding of and Treatment Paradigm for Newly-Diagnosed <i>TP53</i>-Mutated Acute Myeloid Leukemia
by: Rory M. Shallis, et al.
Published: (2021-12-01)

Unmet Horizons: Assessing the Challenges in the Treatment of <i>TP53</i>-Mutated Acute Myeloid Leukemia
by: Christos Stafylidis, et al.
Published: (2024-02-01)

TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome
by: Pimjai Niparuck, et al.
Published: (2021-10-01)

<i>TP53</i> Mutation in Acute Myeloid Leukemia: An Old Foe Revisited
by: Dong-Yeop Shin
Published: (2023-09-01)

TP53 Mutations in AML Patients Are Associated with Dismal Clinical Outcome Irrespective of Frontline Induction Regimen and Allogeneic Hematopoietic Cell Transplantation
by: Davidson Zhao, et al.
Published: (2023-06-01)

Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status
by: Javier Octavio Mejía-Hernández, et al.
Published: (2022-08-01)

<i>TP53</i> Mutant Acute Myeloid Leukemia: The Immune and Metabolic Perspective
by: Federico Zingarelli, et al.
Published: (2022-11-01)

TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia
by: Ramy Rahmé, et al.
Published: (2023-04-01)

Functional Classification of <i>TP53</i> Mutations in Acute Myeloid Leukemia
by: Sayantanee Dutta, et al.
Published: (2020-03-01)

<i>TP53</i> Combined Phenotype Score Is Associated with the Clinical Outcome of <i>TP53</i>-Mutated Myelodysplastic Syndromes
by: Mariko Yabe, et al.
Published: (2021-11-01)

<i>TP53</i> in Acute Myeloid Leukemia: Molecular Aspects and Patterns of Mutation
by: Binsah George, et al.
Published: (2021-10-01)

<i>TP53</i> in Myelodysplastic Syndromes: Recent Biological and Clinical Findings
by: Cosimo Cumbo, et al.
Published: (2020-05-01)

TP53 in Myelodysplastic Syndromes
by: Yan Jiang, et al.
Published: (2021-10-01)

Deep Molecular and In Silico Protein Analysis of p53 Alteration in Myelodysplastic Neoplasia and Acute Myeloid Leukemia
by: Kristóf Madarász, et al.
Published: (2022-11-01)

Molecular characterization of AML‐MRC reveals TP53 mutation as an adverse prognostic factor irrespective of MRC‐defining criteria, TP53 allelic state, or TP53 variant allele frequency
by: Davidson Zhao, et al.
Published: (2023-03-01)

<i>TP53</i> Expression and Mutational Analysis in Hematological Malignancy in Jeddah, Saudi Arabia
by: Heba Alkhatabi, et al.
Published: (2022-03-01)

A thiol‐bound drug reservoir enhances APR‐246‐induced mutant p53 tumor cell death
by: Sophia Ceder, et al.
Published: (2021-02-01)

Mesonephric Adenocarcinoma of the Vagina Harboring <i>TP53</i> Mutation
by: Hyunjee Lee, et al.
Published: (2022-01-01)

Prediction of Response and Survival Following Treatment with Azacitidine for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation
by: Christina Rautenberg, et al.
Published: (2020-08-01)

Allogeneic haematopoietic stem cell transplantation with decitabine-containing preconditioning regimen in TP53-mutant myelodysplastic syndromes: A case study
by: Yuxin Wang, et al.
Published: (2022-07-01)

Exploring the Functions of Mutant p53 through <i>TP53</i> Knockout in HaCaT Keratinocytes
by: Daniil Romashin, et al.
Published: (2024-02-01)

p53 Dysregulation in Breast Cancer: Insights on Mutations in the <i>TP53</i> Network and p53 Isoform Expression
by: Luiza Steffens Reinhardt, et al.
Published: (2023-06-01)

Whole-Body MRI Surveillance—Baseline Findings in the Swedish Multicentre Hereditary <i>TP53</i>-Related Cancer Syndrome Study (SWEP53)
by: Meis Omran, et al.
Published: (2022-01-01)

Integrative Analysis of the Role of <i>TP53</i> in Human Pan-Cancer
by: Tingting Liu, et al.
Published: (2023-11-01)

Intronic <i>TP53</i> Polymorphisms Are Associated with Increased <i>Δ133TP53</i> Transcript, Immune Infiltration and Cancer Risk
by: Ramona A. Eiholzer, et al.
Published: (2020-09-01)

Influence of <i>TP53</i> Mutation on Survival of Diffuse Large B-Cell Lymphoma in the CAR T-Cell Era
by: Edit Porpaczy, et al.
Published: (2021-11-01)

<i>TP53</i> Abnormalities and MMR Preservation in 5 Cases of Proliferating Trichilemmal Tumours
by: Raquel Martín-Sanz, et al.
Published: (2021-05-01)

<i>TP53</i> Mutations as a Driver of Metastasis Signaling in Advanced Cancer Patients
by: Ritu Pandey, et al.
Published: (2021-02-01)

Immature Immunoglobulin Gene Rearrangements Are Recurrent in B Precursor Adult Acute Lymphoblastic Leukemia Carrying <i>TP53</i> Molecular Alterations
by: Silvia Salmoiraghi, et al.
Published: (2020-08-01)

p53/<i>TP53</i> Status Assessment in Gastroesophageal Adenocarcinoma
by: Elisa Boldrin, et al.
Published: (2023-05-01)

<i>APC</i> and <i>TP53</i> Mutations Predict Cetuximab Sensitivity across Consensus Molecular Subtypes
by: Ramya Thota, et al.
Published: (2021-10-01)

Presence of Concurrent <i>TP53</i> Mutations Is Necessary to Predict Poor Outcomes within the <i>SMAD4</i> Mutated Subgroup of Metastatic Colorectal Cancer
by: Chongkai Wang, et al.
Published: (2022-07-01)

A Pan-Cancer Assessment of <i>RB1</i>/<i>TP53</i> Co-Mutations
by: Ling Cai, et al.
Published: (2022-08-01)

Allogenic hematopoietic stem cell transplantation outcomes of patients aged ≥ 55 years with acute myeloid leukemia or myelodysplastic syndromes in China: a retrospective study
by: Lu Gao, et al.
Published: (2024-01-01)

The <i>TP53</i> Codon 72 Arginine Polymorphism Is Found with Increased <i>TP53</i> Somatic Mutations in HPV(−) and in an Increased Percentage among HPV(+) Norwegian HNSCC Patients
by: Svein Erik Moe, et al.
Published: (2023-06-01)

Early <i>TP53</i> Alterations Shape Gastric and Esophageal Cancer Development
by: Pranshu Sahgal, et al.
Published: (2021-11-01)